跳至主要内容
临床试验/PACTR202101794541918
PACTR202101794541918已完成未知

Comparative Study Between Oxytocin Versus Tranexamic Acid &Ethamsylate to Reduce Blood Loss Intraoperative and Postoperative During Elective Cesarean Delivery

Sayed Galal0 个研究点目标入组 230 人开始时间: 2020年12月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
230

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • 1-Pregnant females admitted for elective Cesarean Section
  • 2-Gestational age (38 to 41 weeks)
  • 3- Age of the participants: 20y to 40 years
  • 4- Body Mass Index (18.5 - 29.9)
  • 5-Singleton living fetus.
  • 6-No medical disorders.

排除标准

  • 1 - Medical and surgical disorders as thyroid dysfunction, which was excluded by routine thyroid function test (free T3, free T4, and thyroid-stimulating hormone(TSH), all of them should be within normal limits).
  • 2 -Bleeding tendency, was excluded by platelet count, coagulation time, bleeding time, prothrombin time, partial thromboplastin time, and thrombin time (all should be within normal).
  • 3 -Acute and chronic liver or kidney diseases; blood disorders, such as anemia.
  • 4 -Allergy to Tranexamic acid or any drug used.
  • 5 -Risk factors for PPH, such as polyhydramnios, fetal macrosomia, antepartum hemorrhage.
  • 6 - Abnormal placentae such as placenta previa and placental abruption.
  • 7 -Pregnancy complications such as severe pre-eclampsia, Gestational HTN, Gestational DM, and multi Fetal pregnancies, those requiring blood transfusion.
  • 8 - Patients who refused spinal anesthesia.

研究者

发起方
Sayed Galal

相似试验